Argent Biopharma (AU:RGT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argent BioPharma Ltd., a leader in multidisciplinary drug discovery within the biopharmaceutical sector, has released its audited Annual Financial Report and Corporate Governance Statement for the fiscal year ending June 30, 2024. Investors and interested parties can access these key documents through the URLs provided in the release. The company continues to focus on leveraging nanotechnology for developing therapies, especially for the central nervous system and immunology treatments.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.